CreditRiskMonitor is a financial risk analysis and news service for credit, supply chain and financial professionals.  Our strength in coverage spans 58,000 global public companies, totaling about $70 trillion in corporate revenue.  We also offer solutions that can help ease private company financial risk assessment.  Leading corporations around the world – including more than 35% of the Fortune 1000, plus thousands more worldwide – rely on us to help them stay ahead of financial risk quickly, accurately and cost-effectively. 

A partial report preview for Elanix Biotechnologies AG is shown below.  Where indicated by "Yes," CreditRiskMonitor contains this information in its extensive database.  To get access to the full report and learn more about CreditRiskMonitor's robust financial risk analysis and timely news service, request a personalized demo and free trial today.

If you are already a subscriber and want to access the full report, click here.

Elanix Biotechnologies AG
Georg-Glock-Str. 4
Phone: +49 61171627677p:+49 61171627677 Dusseldorf, DE-40474  Germany Fax: +49 61171692754f:+49 61171692754

This company is no longer actively traded on any major stock exchange.

Business Summary
Elanix Biotechnologies AG is a Germany-based provider of solutions for tissue regeneration. The Company develops and commercializes products for acute wound care, dermatological and gynecological applications, and also provides cell technology services. It develops bioresorbable & bioactive skin dressing derived from progenitor skin fibroblasts. The Company's product portfolio comprises Gyn-RepAir cream, which contains a Cell Free Protein Complex (CFPC), and which includes various proteins such as collagen and fibronectin, as well as RepAir-A N cream. The Company also produces validated progenitor skin cells used in drug discovery, toxicity testing and cosmetic applications. It is a spin-out from the University Hospital of Lausanne (CHUV) in Switzerland.
(Source: Company's Website)

Scores and Ratings
FRISK®
Score
Z''
Score
PAYCE®
Score
DBT
Index
Moody's
Rating
Fitch
Rating
DBRS
Rating
-Yes-----

Financials, News and Filings
Latest
Statement
Last
Audit

News
SEC
Filings
Bankruptcy
Filings
Suit &
Judgment
Filings
Tax
Lien
Filings
6/30/201912/31/2016Yes----

Officers and Directors

Title

Name

Age
Title
Date
Start
Date
Chairman of the Supervisory Board PeterEck 11/12/2013 11/12/2013
Member of the Management Board ArminSchulz 11/19/2013 11/19/2013
Vice Chairman of the Supervisory Board JamesValotton 11/12/2013 11/12/2013
Member of the Supervisory Board LeopoldDieck 76 2/5/2016
Member of the Supervisory Board RichardPajer 1/31/2014 1/31/2014

Business Names
Business Name
Elanix-Technologies SA
Repair-A SA

General Information
Outstanding Shares: 8,080,902 (As of 6/30/2019)
Shareholders: 938
Stock Exchange: DUS
Fax Number: +49 61171692754


Copyright © 2023 CreditRiskMonitor.com (Ticker: CRMZ). All rights reserved.     
By using this website, you accept the Terms of Use Agreement.
Wednesday, August 9, 2023